Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Heart Failure Comorbidities
Review Article
Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado
Review Article
Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al
Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al
Nikhil Ahluwalia, Shohreh Honarbakhsh, Ross Hunter, et al
Nadirah Abd Wahid, Aisya Natasya Musa, Sazzli Kasim, et al
Radcliffe Cardiology
Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al
Bahira Shahim, Chris J Kapelios, Gianluigi Savarese, et al
Video Series
Fausto J Pinto, John Spertus, , et al
Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al
Review Article
Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al
Review Article
Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado
About
Media
Video Series
Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al
Robert Mentz, Harriette Van Spall
William T Abraham, Marianna Adamo, Stefan Anker , et al
James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al
Media
Javed Butler, Dinesh Khullar, John JV McMurray, et al
Joe Carver, Osnat Itzhaki Ben Zadok, Jose Álvarez-Cardona
Video Series
HFSA 2025 Late-Breaking Science CollectionArticles
EPCs and Innovative Strategies for Endothelial Dysfunction in Heart Failure
Published:
18 August 2025
Citation:
Cardiac Failure Review 2025;11:e21.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
56
- Citations: 4
-
Read time: 26m 40s
Aldosterone Synthase Inhibitors
Published:
18 August 2025
Citation:
Cardiac Failure Review 2025;11:e20.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
207
- Citations: 10
-
Read time: 24m 34s
Understanding the Role of GLP-1 RAs in the Treatment of HF
Published:
14 August 2025
Citation:
Cardiac Failure Review 2025;11:e19.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
124
- Citations: 1
-
Read time: 15m 45s
Cardiac Troponins in Kidney Disease
Published:
13 August 2025
Citation:
European Cardiology Review 2025;20:e22.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
-
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Downloads:
208
- Citations: 2
-
Read time: 23m 21s